The creation of Epclusa and its pangenotype with highly effective treatment of patients with hepatitis C could finally solve all the remaining problems of the fight against the malicious virus.
But everything again came up against the exorbitantly high price of the drug, prescribed by the pharmaceutical giant Gilead Sciences. Not everyone can pay for the treatment of more than fifty thousand dollars.
And Gilead once again grants a license and production technology to several companies. Among the first to organize the production of generic (analogous) Epclusa was able to Beacon Pharma Ltd. – a pharmaceutical company from Bangladesh. A little later, production began at Natco Pharma. The cost of Velpanat from Natco was ten times less than that of the official original. You can buy Generic sofosbuvir velpatasvir price is very cheap in India